Company intelligence / Profile preview

Coapt

Chicago, Illinois, USAcoaptengineering.com ↗

Ownership: Private
Development stage: Other

Overview

Coapt’s Complete Control Gen2 system uses advanced machine learning to decode users’ natural muscle signal patterns, enabling intuitive and personalized control of upper-limb prostheses. The technology has received FDA Class II clearance and is commercially available. It allows users to calibrate their device easily via an app, improving quality of life for amputees by making bionic limbs feel more like natural extensions of the body.

Therapeutic areas: Rare DiseasesOther
Modalities: DeviceNon-pharmacological therapy
Industry: Assistive Medical Devices

Partnerships

Shirley Ryan AbilityLab

Beyond the preview

Go deeper on Coapt.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coapt.

Explore the full profile